iHealth Flu A&B/COVID-19 3-in-1 Rapid Test 6 Tests/Family Pack
The iHealth COVID-19 & Flu A/B Antigen Rapid Home Test is a simple at-home test that detects COVID-19, Influenza A, and ...Expand description
The iHealth COVID-19 & Flu A/B Antigen Rapid Home Test is a simple at-home test that detects COVID-19, Influenza A, and Influenza B using a nasal swab. It delivers results in about 15 minutes and is authorized for self-use in individuals 14 years and older, with adult assistance required for children ages 2 to 13. The test is easy to perform with four quick steps—swab, mix, drop, and read—and shows clear result lines for each virus. While convenient and fast, it is authorized under FDA Emergency Use Authorization, meaning negative results may still need confirmation from a healthcare provider. It is available in different pack sizes, from small personal kits to larger family and bulk packs.
iHealth
iHealth Labs is dedicated to empowering individuals to lead healthier lives through the development of innovative digital health solutions. The company specializes in designing and manufacturing consumer-friendly medical devices that seamlessly connect to the cloud, enabling users to efficiently monitor and manage their health.
Customer Reviews
No reviews yet
We're working on collecting customer reviews for this product.
A fast, reliable, and easy-to-use at-home test that screens for three common respiratory infections—COVID-19, Influenza A, and Influenza B—using a simple nasal swab. Designed for quick self-testing, the kit provides results within 15 minutes, helping individuals and families make informed health decisions without waiting for lab results.
Features & Benefits:
- Detects COVID-19, Flu A, and Flu B with a single sample.
- Quick results in about 15 minutes.
- Simple 4-step process: swab, mix, drop, and read.
- Clear result lines indicate the presence of each virus; includes a control line for accuracy.
- Suitable for ages 14+ for self-testing; adult-assisted testing for ages 2–13.
- Authorized under FDA Emergency Use Authorization (EUA) for in-vitro diagnostic use.
- Helps distinguish between flu and COVID-19 symptoms, which often overlap.
Limitations:
- Negative results do not completely rule out infection; follow-up with a healthcare provider may be necessary.
- Authorized under EUA, not fully FDA-approved.
- Performance against all emerging COVID-19 variants may vary.
